Corcept Therapeutics, Inc. (CORT)
72.96
-0.75
(-1.02%)
USD |
NASDAQ |
Nov 13, 16:00
72.96
0.00 (0.00%)
After-Hours: 17:03
Corcept Therapeutics Price to Book Value : 9.570 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 9.669 |
| November 11, 2026 | 9.776 |
| November 10, 2026 | 9.622 |
| November 09, 2026 | 9.841 |
| November 06, 2026 | 9.546 |
| November 05, 2026 | 9.396 |
| November 04, 2026 | 10.39 |
| November 03, 2026 | 10.75 |
| November 02, 2026 | 10.55 |
| October 30, 2026 | 10.64 |
| October 29, 2026 | 11.27 |
| October 28, 2026 | 11.32 |
| October 27, 2026 | 11.49 |
| October 26, 2026 | 11.43 |
| October 23, 2026 | 11.26 |
| October 22, 2026 | 14.10 |
| October 21, 2026 | 15.25 |
| October 20, 2026 | 15.28 |
| October 19, 2026 | 14.70 |
| October 16, 2026 | 14.45 |
| October 15, 2026 | 14.87 |
| October 14, 2026 | 15.25 |
| October 13, 2026 | 15.45 |
| October 12, 2026 | 15.90 |
| October 09, 2026 | 15.90 |
| Date | Value |
|---|---|
| October 08, 2026 | 15.55 |
| October 07, 2026 | 15.69 |
| October 06, 2026 | 15.68 |
| October 05, 2026 | 16.01 |
| October 02, 2026 | 15.25 |
| October 01, 2026 | 14.96 |
| September 30, 2026 | 15.12 |
| September 29, 2026 | 17.54 |
| September 28, 2026 | 17.68 |
| September 25, 2026 | 17.75 |
| September 24, 2026 | 18.12 |
| September 23, 2026 | 17.27 |
| September 22, 2026 | 17.97 |
| September 21, 2026 | 17.40 |
| September 18, 2026 | 16.86 |
| September 17, 2026 | 17.56 |
| September 16, 2026 | 17.10 |
| September 15, 2026 | 16.95 |
| September 14, 2026 | 17.10 |
| September 11, 2026 | 17.25 |
| September 10, 2026 | 17.57 |
| September 09, 2026 | 17.69 |
| September 08, 2026 | 17.43 |
| September 04, 2026 | 17.07 |
| September 03, 2026 | 17.25 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 1.851 |
| Phibro Animal Health Corp. | 3.498 |
| Illumina, Inc. | 10.01 |
| Eli Lilly & Co. | 33.76 |
| Merck & Co., Inc. | 8.118 |
Price to Book Value Related Metrics
| PE Ratio | 57.58 |
| PS Ratio | 8.818 |
| PEG Ratio | 1.286 |
| Price to Free Cash Flow | 43.66 |
| Price | 72.96 |
| Earnings Yield | 1.74% |
| Market Cap | 7.979B |
| PEGY Ratio | 1.286 |
| Operating PE Ratio | 76.62 |
| Normalized PE Ratio | 57.58 |